BU and Johnson & Johnson Innovation Team Up to Fight Lung Cancer

Tuesday, June 6, 2018 Written by: Sara Rimer and Art Jahnke | Source: BUToday New Medical Campus center hopes to speed development of interventions and cures In what Boston University President Robert A. Brown envisions as a model for industry and academia collaborating to improve human health, BU has launched a five-year translational research alliance with Johnson & […]

BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition

Published April 2018 Provided by: American Association for Cancer Research Publications | Source: Molecular Cancer Research Guillaume P. Andrieu and Gerald V. Denis DOI: 10.1158/1541-7786.MCR-17-0568 Abstract Transcriptional programs in embryogenesis and cancer, such as the epithelial-to-mesenchymal transition (EMT), ensure cellular plasticity, an essential feature of carcinoma progression. As effectors of signal transduction, the bromodomain and extraterminal […]

Insight into chromatin therapies for breast cancer could aid personalized medicine

Wednesday, February 7, 2018 Provided by: Boston University School of Medicine | Source: Medical Xpress Most traditional chemotherapy for cancer has dangerous side effects, but new research is finding ways to develop ‘targeted agents’ that reduce the side effects and are better tailored to individual patient needs. While these innovations are exciting, a new study shows how certain cancer […]

Avrum Spira Leads “Stand Up to Cancer” Dream Team

Wednesday, November 1, 2017 Written by: Sara Rimer | Source: BUToday Armed with $12 million, researchers aim for early detection of lung cancer Can lung cancer, rarely diagnosed until it’s in an advanced and deadly stage, be nipped in the bud? Avrum Spira and his team intend to find out. Spira (ENG’02), Alexander Graham Bell Professor in Health […]

Finding Lung Cancer in the Nose

Tuesday, February 28, 2017 Written by: Barbara Moran | Source: BUToday Lung cancer is the deadliest form of cancer in the United States—and in the world. According to the National Cancer Institute, it accounts for more than a quarter of cancer deaths in this country, killing about 158,000 people in 2016. Because lung cancer is so lethal, many […]

Nasal Swab Shows Promise in Confirming Lung Cancers

Monday, February 27, 2017 Written by: Randy Dotinga | Source: HealthDay News Lung cancer remains by far the leading cancer killer because it is so often caught too late. But researchers now say it may someday be possible to quickly confirm the disease after a CT scan, by using a simple nasal swab. The key is […]

Six Junior Faculty Receive Career Development Awards

Written by: Amy Laskowski | Source: Bostonia Jerry Chen received quite a present just three months after arriving at BU. Chen, a College of Arts & Sciences assistant professor of biology, is the winner of this year’s Stuart and Elizabeth Pratt Career Development Professorship, which highlights excellence within CAS. A neuroscientist who uses the sensory input from […]

Cancer Treatment Goes Local

Written By: Sara Elizabeth Cody | Source: BU Research When it comes to treating cancer, one Boston University researcher is going local. Mark Grinstaff, a BU College of Engineering professor of biomedical engineering and materials science and engineering, published two studies in January 2016 that offer new approaches to the treatment of two intractable cancers—mesothelioma and esophageal cancer—by […]

New Proteins Discovered that Link Obesity-driven Diabetes to Cancer

March 23, 2016 | Source: BUSM For the first time, researchers have determined how bromodomain (BRD) proteins work in type 2 diabetes, which may lead to a better understanding of the link between adult-onset diabetes and certain cancers.  The findings, which appear in PLoS ONE, show that reducing levels in pancreatic beta cells of individual […]